|40.81||+0.95 / +2.38%|
As of 3:59pm ET
|40.81||0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 53.00, with a high estimate of 53.00 and a low estimate of 53.00. The median estimate represents a +29.87% increase from the last price of 40.81.
The current consensus among 1 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.